Stay updated on METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Sign up to get notified when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FZPekdQtXuPOgP9wVXNNSR8FeJgk.uncropped.jpg&w=3840&q=75)
Latest updates to the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0, with 5 locations now included, replacing the previous version v2.9.7.SummaryDifference0.2%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.2%
- Check16 days agoChange DetectedDifference0.2%
- Check18 days agoChange DetectedDifference0.2%
- Check22 days agoChange DetectedDifference0.2%
- Check24 days agoChange DetectedThe value Antineoplastic Agents, Immunological Antineoplastic Agents Nivolumab Oxaliplatin has been updated to Antineoplastic Agents Antineoplastic Agents, Immunological Oxaliplatin Nivolumab. This change represents a reordering of the agents in the list, with Nivolumab and Oxaliplatin switching positions.SummaryDifference0.2%
Stay in the know with updates to METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Enter your email address, and we'll notify you when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.